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In 1962, the neurologist Macdonald Critchley stated 
“Nothing has been said about the possible role in etiology of the 
previous habit of athleticism.  I have the uncomfortable feeling that 
a past history of unnecessary muscular movement carried out for 
no obvious reason may be followed in later life by the 
development of motor neuron disease in a statistically significant 
number of cases.” 
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THE ROLE OF CHRONIC TRAUMATIC ENCEPHALOPHATY ON 
AMYOTROPHIC LATERAL SCLEROSIS  
ANDREA STEEN 
ABSTRACT 
 It has been postulated that there could be a connection between traumatic brain 
injury (TBI) and motor neuron disease (MND), including amyotrophic lateral sclerosis 
(ALS).  As chronic traumatic encephalopathy (CTE) is caused by repeated TBI and is a 
newly examined disease, there has been little evaluation of the potential relationship 
between CTE and ALS.   It was proposed that CTE is a risk factor for not only MND, but 
also ALS.  There is significant evidence that even a single TBI is a risk factor for 
Parkinson’s disease (PD), thought to be invoked by the inflammatory process that the 
brain undergoes following a TBI.  General rigorous physical activity with trauma to the 
trunk or extremities does not appear to be a risk factor for ALS.  However, physical 
activity with associated head traumas, especially repeated head traumas, does seem to 
increase the likelihood of developing ALS.  The biological mechanism for this is 
suspected to be increase in free radicals during exercise in individuals who are 
predisposed to decreased antioxidant function.  Additionally, individuals who have 
suffered repeated head trauma, even amongst the general population in a non-athletic 
setting, has been shown to drastically increase the individual’s chance of developing 
ALS.  
CTE, which is most common in athletes, is speculated to be caused by TAR	  DNA-­‐binding	  protein	  43	  (TDP-­‐43),	  tau	  neurofibrillary tangle (NFT), and beta-amyloid (Aβ) 
	  	   vi 
protein inclusions in brain tissue following a multitude of TBI during high level sport 
activity.  There are individuals who suffer initially CTE, followed by ALS, indicating 
CTE is clearly a risk factor for ALS.  Anatomically, the TDP-43, NTF, and Aβ inclusions 
are present in the brain tissue of both individuals with CTE alone as well as the 
individuals with CTE and ALS.  The anatomic difference between these two pathologies 
is the inclusion of these three proteins in the spinal cord of ALS patients as well.  
 Unfortunately, there are indications that previous studies of professional athletes 
and their development of ALS have presented with significant issues including 
confounding factors of the subpopulation and sample sizing.  Additionally, the 
anatomical cause of TBI leading to ALS is still unknown.  Further evaluation on the 
relationship between head injury and ALS must be dedicated to investigating the 
mechanism involved in developed PD versus ALS following TBI.  The biologic sequence 
following TBI that leads to ALS must be examined and compared to individuals whom 
develop ALS but did not suffer TBI.  Moreover, an assessment must be made to 
determine what causes some individuals to develop protein inclusions solely in the brain 
tissue, leading to CTE, and some individuals to have an advancement of the protein 
inclusions into the spinal cord, leading additionally to CTE followed by ALS. 
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INTRODUCTION 
 
Amyotrophic Lateral Sclerosis 
Amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig’s 
disease, “is a progressive neurodegenerative disease that affects nerve cells in the brain 
and the spinal cord” (ALS Association, 2010).  Degeneration of the motor neurons leads 
to neuronal death, which in turn leads to atrophy of the muscles innervated by those 
motor neurons (Figure 1).  Ultimately the brain loses its ability to communicate with 
those muscles as well as the ability of the body to make voluntary movements (ALS 
Association, 2010).  At this time, there are no bioidentifiers of ALS, making it a disease 
of exclusion secondary to clinical presentation (Kiernan et al. 2011).    
 
 
 
Figure 1. 3D MRI of patient with primary lateral sclerosis (PLS).  The increased size 
of the sulci and decreased size of the gyri near the arrows are most commonly seen in 
PLS patients, however, they do appear in ALS patients as well.  This is representative of 
the atrophy of the motor neurons in the brain (Kieman et al. 2011). 
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There are four phenotypes of ALS currently identified.  Limb-onset ALS is 
characterized by changes of the limbs, lower and/or upper (Kiernan et al. 2011).  
Specifically, flail-arm variant affects the upper motor neurons and arms and typically 
causes weakness and uncontrolled tendon reflexes, whereas flail-leg variant affects the 
lower motor neurons and legs and presents with weakness and wasting (Wijesekera et al. 
2009).   There is also the progressive muscle atrophy presentation that is associated solely 
with the lower motor neurons, and the primary lateral sclerosis presentation that is 
characterized by spastic movements only in the upper motor neurons (Kiernan et al. 
2011).  The final presentation is bulbar palsy that uniquely affects the oropharyngeal 
muscles resulting in distorted speech, tongue wasting, and gag and jaw jerk (Duffy et al. 
2007).  Pure bulbar palsy ALS is associated with the worst prognosis, i.e. the fastest 
progression of the disease, and strangely, typically only affects women over the age of 65 
(Talbot 2009). 
A significant complication from ALS is dysphagia, difficulty swallowing 
associated with an increase in the amount of time it takes to move food from the mouth to 
the stomach (Kiernan et al. 2011).  This complication is what often contributes to the 
secondary complication of malnutrition.   Another issue experienced by ALS patients that 
contributes to malnutrition is hypermetabolism (Funalot et al. 2009).  Hypermetabolism, 
defined as an abnormally elevated basal metabolism, is present in 50-60 % of ALS 
patients and associated with a decrease in life expectancy (Desport et al. 2005). 
Leigh (2003) also describes how the weakening of the respiratory muscles, 
including the diaphragm, leads to significant associated respiratory conditions such as 
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hypoventilation. Dyspnea, or difficulty breathing, is also an associated symptom of ALS 
and initially is seen connected with exertion (Leigh 2003).  Additionally “death becomes 
imminent once patients develop dyspnea at rest” without the intervention of a 
tracheostomy and ventilator (Kiernan et al. 2011).   The weakening of respiratory 
muscles also frequently causes a secondary infection of pneumonia.   
Hypersalivation is another symptom of ALS that also causes pneumonia, 
specifically aspiration pneumonia (Miller et al. 2009).  This hypersalivation often times 
has psychological effects on ALS patients such as embarrassment.  ALS patients often 
have a multitude of other psychological effects associated with their disease.  Anxiety is 
the most common mental health issue with 30% of ALS patients experiencing anxiety, 
and often times linked insomnia (Kurt et al. 2007).  Between 9-11% of ALS patients 
suffer from depression, which is also connected to insomnia.  In addition to risk of 
depression, according to a population-based study in Sweden of 6,642 ALS patients 
between 1965 and 2004, there is a significant increased risk of suicide, especially in the 
first year after diagnosis of the disease (Fang et al. 2009).  Another psychological change 
affecting 20-50% of ALS patients is pseudobulbar affect characterized by uncontrolled 
emotional expression including excessive laughing or crying (Miller et al. 2009).   
Kiernan et al. (2011) claims that approximately 10% of ALS cases are caused by 
genetic familial inheritance with six known mutations leading to the disease: 
• Superoxide dismutase 1 (SOD1) - encodes for copper/zinc ion-binding 
superoxide dismutase, with mutation causing a toxic gain of function 
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• TAR DNA-binding protein 43 (TDP-43) - encodes for TDP-43 that is 
involved in gene expression and regulation  
• FUS (also called TLS) - encodes fusion in sarcoma that is involved in gene 
expression and regulation 
• ANG - encodes angiogenin, ribonuclease, RNase A family, 5 and is a 
hypoxia-sensitive gene that regulates RNA transcription 
• OPTN - encodes optineurin, where mutations inhibit the inhibition of 
activation of NFκB, and change the cytoplasmic distribution of optineurin 
• C9ORF72 - a GGGGCC hexanucleotide repeat expansion in a non-coding 
region of the chromosome 9 open-reading frame 72 gene (Stewart et al. 
2012) 
There is also a unique ALS-PD combination that is caused by ingesting a species 
of bat (flying fox) that consumes cycad seeds (Cox et al. 2002). Cycad seeds contain a 
large concentration of neurotoxic amino acid, β-methyl-amino-L-alanine, that leads to a 
constellation of neurodegenerative disease processes similar to ALS and PD.  This 
disease process was found in high frequency in a population of people living in Guam, as 
these bats are considered a delicacy by Guam natives. 
There is an interesting additional disease process caused by mutations of TDP-43 
or FUS, each a DNA/RNA binding protein (Kiernan et al. 2011).  These proteins have a 
multifunctional role in transcription, RNA splicing and transport, and microRNA 
processing.  Because they are involved in these significant processes of the cell, 
mutations of these proteins cause not only ALS, but also a second disease process called 
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frontotemporal dementia (FTD), but with less frequency than ALS.  FTD and ALS, as 
well as other neurodegenerative diseases, commonly have atypical intracellular protein 
aggregation as a pathological element of their disease process (Mackenzie et al. 2010).  It 
has recently been identified that almost all cases of sporadic ALS demonstrate TDP-43 
ubiquinated cytoplasmic inclusions of neurons (Kiernan et al. 2011). 
SOD1 appears to be the most common mutation present in familial ALS at 20% 
of total cases, and curiously mutations in SOD1 are present in 5% of sporadic ALS cases 
(Kiernan et al. 2011).  The function of SOD1’s involvement in the early death of motor 
neurons is not fully understood, however, it is known that the gain of function mutation 
causes formation the generation of free radicals causing cell injury and death.  SOD1 
mutation is also responsible for misfolding of peptides leading to a second type of 
intracellular aggregate, which eventually the disruption of axon transportation and 
essential cellular activity (Figure 2).  In general, though, the death of motor neurons in 
ALS is a very complicated and multifactorial. 
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Figure 2. The genetic factors and molecular pathways involved in motor neuron 
death in ALS.  The square has a TDP-43/FUS aggregate enclosed.  The circle has a 
SOD1 aggregate enclosed.  These aggregates lead to disruption of neuron-to-neuron 
communication as well as fundamental intracellular processes and eventual death of the 
cell (figure amended from Vucic et al. 2014). 
 
Sporadic ALS makes up the remaining 90% of cases.  A study done in 2000 found 
that sporadic ALS might be caused by an enterovirus nucleic acid sequence present in the 
gray matter of spinal cord (Berger et al. 2000).  The nuclei acid sequence was found in 
the gray matter in 88% of ALS cases versus 3.4% of controls.  Sporadic ALS is also 
connected to several potential environmental risk factors.  Among them includes 
exposure to formaldehyde as well as smoking (DynaMed, Feb 2014).  Strangely, the 
number of younger siblings a person has is also connected to the development of ALS; 
the more younger siblings an individual has, there is an increased likelihood of 
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developing the disease (Fang et al. 2008).  Within that finding, there is an even greater 
increase in the potential for an individual to develop ALS if their younger siblings are 
born six or more years after the patient.  Additionally, maternal age at birth has been 
shown to increase the chances of developing sporadic ALS, including mothers who are 
either less than twenty years old or greater than forty-one years old at the time of the 
individual’s birth.  A newly suggested risk factor for sporadic ALS is a lifetime of 
strenuous physical activities including professional sports, but the cause for this 
development remains unknown (Kiernan et al. 2011).   
 Factors that have been found to not be associated with increased risk for 
developing ALS includes individuals taking statins for treatment of high cholesterol 
(DynaMed, Feb 2014).  According to data collected by the FDA, there is no increase 
incidence of ALS in people taking statins versus controls.  Huss et al. also did a study 
examining the potential relationship between individuals living near power lines, 
specifically 220-380 kilovolts, and development of neurodegenerative disease and found 
no connection (Huss et al. 2008). 
The life expectancy of ALS is dependent on clinical presentation, the rate of its 
progression, timing of diaphragm involvement, and nutrition of the patient (Kiernan et al. 
2011).  The Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) is a 
number scale that was created for physicians to monitor the progression of ALS in 
several categories as well as assess the response to interventions and treatment 
(Cedarbaum et al. 1999).  The original scale placed an inappropriately large emphasis on 
limb and bulbar changes and was revised to place the proper emphasis on respiratory 
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decline.  The Revised ALSFRS (ALSRFS-R) was created to account for the assessment 
of dyspnea and need for ventilator intervention (Table 1).  Scoring ranges from 40 points 
in a healthy individual to 0 points being the worse prognosis.  
 
 
Table 1. The ALSFRS-R.  The symptomatologies of ALS and points associated with 
current clinical presentation (table amended from Cedarbaum et al. 1999). 
 
1. Speech 
4 
3 
2 
1 
0 
 
Normal speech processes 
Detectable speech disturbance 
Intelligible with repeating 
Speech combined with nonvocal communication 
Loss of useful speech 
2. Salivation 
4 
3 
2 
1 
0 
 
Normal 
Slightly but definite excess of saliva in mouth; may have 
nighttime drooling 
Moderately excessive saliva; may have minimal drooling 
Marked excessive of saliva with some drooling 
Marked drooling; requires constant tissue or handkerchief  
3. Swallowing 
4 
3 
2 
1 
0 
 
Normal eating habits 
Early eating problems – occasional choking 
Dietary consistency changes 
Need supplemental tube feeding 
NPO (exclusively parental or enteral feeding) 
4. Handwriting 
4 
3 
2 
1 
0 
 
Normal 
Slow or sloppy; all words are legible 
Not all words are legible 
Able to grip pen but unable to write 
Unable to grip pen 
5. Cutting food and handling 
utensils 
4 
3 
2 
1 
0 
 
 
Normal 
Somewhat slow and clumsy, but no help needed 
Can cut most food, although clumsy and slow; some help needed 
Food must be cut by someone, but can still feed slowly 
Needs to be fed 
6. Dressing and hygiene 
4 
3 
2 
1 
0 
 
Normal function 
Independent and complete self-care with effort or decreased 
efficiency 
Intermittent assistance or substitute methods 
Needs attendant for self-care 
Total dependence 
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Table 1.  (Continued) The ALSFRS-R.  
  
7. Turning in bed and 
adjusting bed clothes 
4 
3 
2 
1 
0 
 
 
Normal 
Somewhat slow and clumsy, but no help needed 
Can turn alone or adjust sheets, but with great difficulty 
Can initiate, but not turn or adjust sheets alone 
Helpless 
8. Walking 
4 
3 
2 
1 
0 
 
Normal  
Early ambulation difficulties 
Walks with assistance 
Nonambulatory functional movement 
No purposeful leg movements 
9. Stair climbing 
4 
3 
2 
1 
0 
 
Normal 
Slow 
Mild unsteadiness or fatigue 
Needs assistance 
Cannot do 
10. Dyspnea (new) 
4 
3 
2 
1 
0 
 
None 
Occurs when walking 
Occurs with one or more of the following: eating, bathing, or dressing 
Occurs at rest, difficulty breathing when either sitting or lying 
Significant difficulty, considering using mechanical respiratory support 
11. Orthopnea (new) 
4 
3 
 
2 
1 
0 
 
None 
Some difficulty sleeping at night due to shortness of breath, does not 
routinely use more than two pillows 
Needs extra pillows in order to sleep (more than two) 
Can only sleep sitting up 
Unable to sleep 
12. Respiratory 
insufficiency (new) 
4 
3 
2 
1 
0 
 
 
None 
Intermittent use of BiPAP 
Continuous use of BiPAP during the night 
Continuous use of BiPAP during the day and night 
Invasive mechanical ventilation by intubation or tracheostomy 
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 Currently, there is no cure for ALS and there is no treatment that stops or reverses 
the progression of ALS (ALS Association, 2010).  Miller et al. states that treatment for 
ALS is solely for the purpose of symptomatic control as well as maintenance and comfort 
for the patient (Miller et al. 2009).  There are suggested treatments for specific symptoms 
and while many treatments increase a patient’s ALSFRS-R, it appears there is little 
evidence for prolonging life (DynaMed, Feb 2014).  For example, once patients develop 
difficulty with swallowing it has been suggested that they be given percutaneous 
endoscopic gastrostomy (PEG) in order to help stabilize weight loss and nutrition; 
however there is a very low level of evidence demonstrating that a PEG prolongs the life 
of ALS patients.  Another symptomatic care that is frequently used with ALS patients is 
endurance-type exercises for the trunk and limbs of patients that may help reduce 
spasticity of muscles, however it does not appear to improve quality of life, fatigue, or 
muscle strength for them (Dal Bello Haas et al. 2013).  For respiratory compromise 
experienced by ALS patients, it appears that noninvasive ventilation does improve quality 
of life for them as well as length survival time and slow the progression of the decline of 
their forced vital capacity (Miller et al. 2009).  Tracheostomy is also considered an 
appropriate surgery for improvement of quality of life for patients looking for long-term 
ventilation support.    
Currently there are only two medications suggested as suitable treatment for ALS 
(DynaMed, Feb 2014).  While there is only a borderline statistical significance for 
Riluzole based on Cochrane review, there is evidence to support prolonged survival for 
ALS patients up to 2-3 months (Miller et al. 2012).  When taken twice a day, Riluzole 50 
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mg is shown to not only prolong life and delay the progression of ALS, but also provide a 
benefit for and limb function.  Unfortunately, it does not appear that Riluzole improves 
muscle stamina or strength in any way.  The second medication commonly prescribed to 
ALS patients is Lithium (DynaMed, Feb 2014).  Unfortunately, there is insufficient data 
to show any improvement in patients’ symptoms or slow of the progression of the disease 
even when combined with Riluzole (Aggarwal et al. 2010).  In fact, the original study 
done by Aggarwal et al. (2010) was terminated early due to the ineffectiveness of the 
medication in changing the outcome for patients. 
 
Traumatic Brain Injury 
Traumatic brain injury (TBI) is characterized by new onset of any or a multitude 
of the follow symptoms: observed neurologic dysfunction, intracranial lesion, and/or any 
period of confusion, disorientation, change in consciousness, or amnesia that may or may 
not be transient.  Additionally, there are three TBI classifications of mild, moderate, and 
severe depending on the presence and/or length of the previously listed symptoms 
(DynaMed, Dec 2014).  Concussions can be considered a subset of TBI that cannot have 
structural injury to the brain as part of their presentation and are classified as mild TBI 
(DynaMed, Oct 2014).   
In addition to the symptoms listed above, The National Institute for Health and 
Care Excellence (NICE) created the Glasgow Coma Scale (GCS) to be utilized when 
evaluating intracranial processes, both traumatic and non-traumatic (NICE, 2014).  The 
best possible score on the GCS scale is a 15 (being most normal baseline neurologic 
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function), with 4 points given for spontaneous eye opening, 6 points given for following 
verbal commands, and 5 points given for oriented conversation Scottish	  Intercollegiate	  Guidelines	  Network (SIGN), 2009).  The GCS additionally provides a breakdown of the 
points given to a patient depending on their history and presentation as well as the 
evaluation and physical examination performed by the clinician or medical provider 
(Table 2).  The total number given to a patient equals the patient’s “Coma Score” out of 
the best possible 15, determining the level of brain injury.  Because GCS can be used 
clinically for both TBI as well as non-traumatic intracranial processes, there is an 
additional breakdown provided by the Scottish Intercollegiate Guidelines Network 
specifically utilized to classify TBI severity levels (Table 3).   
 
Table 2. The GCS and score.  This is the scale utilized by medical providers for clinical 
assessment with this breakdown of points associated with clinical behaviors (SIGN, 
2009). 
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Table 3. Definition of mild, moderate, and severe head injury by GCS score.  This 
score range is applied to patients with a history of a blow to the head or the presence of 
evidence of head trauma, including lacerations, abrasions, or contusions (SIGN, 2009). 
 
 
 
Common symptoms associated with a concussion and/or TBI include physical 
symptoms such as dizziness, balance problems, sleep disturbances, and seizures, 
cognitive symptoms including attention trouble, memory problems, and altered judgment, 
and behavioral and emotional changes causing depression, irritability, and aggression 
(DynaMed, Dec 2014).  More serious physical complications from severe TBI include 
paralysis, muscle weakness, and spasticity.  Guskiewicz et al. (2003) found that with 
minor TBI or concussion, acute neurologic symptoms typically resolve in a patient 
gradually within seven days. A total of 91% of American college football players, who 
were diagnosed with a concussion during their study, were back to baseline with seven 
days, including total resolution of balance and mild cognitive deficits (Guskiewicz et al. 
2003).  
There can be chronic consequences of TBI, however (DynaMed, March 2014).  A 
review done by Nampiaparampil found that chronic pain is present in 75.3% of patients 
who experienced a mild TBI and chronic headaches are present in 57.8% of patients 
(Nampiaparampil 2008).  Chronic tinnitus secondary to TBI when compared to non-
traumatic tinnitus has some significant differences; specifically patients who suffer a TBI 
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are typically younger at the onset of the tinnitus and experience a louder and more severe 
tinnitus (Folmer et al. 2013).  The same survey done by Folmer et al. (2013) found that 
there are more associated symptoms including depression.  Additionally, a systematic 
review and two observational studies also found that 30% of patients greater than sixteen 
years of age who experienced a TBI developed depression (Guillamondegui et al. 2011).  
Some psychiatric conditions found concurrently with depression included anxiety in 
31%-61% of cases, PTSD in 37% of cases, and the less common panic disorder in 15% of 
cases.   
Generalized personality changes including increased irritability, frustration, 
impulsiveness, apathy, and paranoia are present in 50% of patients within the first three 
months after a TBI and 66% of patients during the 6-12 months following a TBI 
(Franulic et al. 2000).  Depending on the degree of head injury, there is a connection with 
development of PTSD in war veterans as well (Hoge et al. 2008).  Nearly 50% of 
veterans who suffered a TBI with associated loss of consciousness met criteria for PTSD.  
For veterans who experienced an altered mental status following a TBI, but no loss of 
consciousness, 27% of them met the PTSD criteria.  Interestingly, for children with 
families with a predisposition for schizophrenia, there is an increased risk for developing 
schizophrenia later if life after experiencing a TBI (Abdel Malik et al. 2003).  An 
additional correlation was found that more severe head injury is related to an earlier onset 
of schizophrenia. 
A single TBI can also lead to a diagnosis of Parkinson disease (PD) (Rugbjerg et 
al. 2008).  According to their population-based case-control study on 13,695 patients with 
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a primary diagnosis of PD there is “an overall 50% increase in prevalence of hospital 
contacts for head injury was seen before the first registration of Parkinson's disease in 
this population.”  Furthermore this association was found to be almost entirely due to TBI 
that occurred within the three months preceding the PD diagnosis.  This is an example of 
TBI leading to a terminal motor neuron disease (MND).  MND include PD, ALS, and 
Huntington disease.   
Interestingly, a seizure following a mild TBI or concussion is not associated with 
the development of the long-term or chronic seizure disorder, epilepsy (McCrory et al. 
1997).  Based on a cohort study of 22 Australian rugby football players who experienced 
a post-concussion or mild TBI seizure within two seconds of the injury, none had 
developed epilepsy within the first 3.5 years after the trauma.  However, there may be an 
increased risk for developing epilepsy following a more severe TBI and post-trauma 
seizure (Annagers et al. 1998).  Another risk factor associated with development of 
epilepsy following a TBI seizure is the patient being greater than 65 years of age. 
While minor TBI rarely lead to anatomical or structural changes in the brain, there 
is a significant increased risk in development of intracranial hemorrhage following even a 
seemingly benign TBI if an individual is anticoagulated, taking Coumadin (Parmar et al. 
2006).  Patients who have undergone a cardiac procedure, such as valve replacement or 
cardiac stent placement, or patients who are at risk of clot formation following an 
orthopedic procedure are prescribed Coumadin to anticoagulate their blood to prevent 
clotting and eventually causing thromboembolism (DynaMed, September 2014).  Of an 
evaluation of the outcome of thirteen patients taking Coumadin who received medical 
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care following a minor TBI, it was found that nine of the patients were found to have 
intracranial hemorrhage and five of the patients died (Parmar et al. 2006).  It was 
concluded that Coumadin patients who have sustained even a very minor TBI or 
concussion require CT head imaging and close monitoring.  
Generally, TBI occurrence is under represented and under diagnosed in the United 
States.  This is assumed to be due to a variety of factors usually including a lack of 
seeking medical care if the patient does not lose consciousness (Silver et al. 2011).  
Another factor affecting the under representation of TBI, especially in sports, is the fact 
that the athletes do not realize they have had an injury or do not feel it is serious enough 
to report (Meehan et al. 2009).  Meehan et al. (2009) found that only 19% of Canadian 
Football League players suffering from a TBI realized they had a concussion.   
It is estimated that between 1.6 and 3.8 million cases of sports-related concussion 
occur annually in United States (Giza et al. 2013).  According to a population cohort 
study performed in the United States between 1997 and 2007, sports-related concussion 
accounted for half of the emergency department visits for concussion between the ages of 
8-13, with ice hockey and American football being the most common sports associated 
with concussions.  The number of children in the 14-19 age category reporting to the 
emergency department for concussions caused by sports was double that of the 8-13 year 
olds (Bakhos et al. 2010).  An additional retrospective cohort study evaluating the trends 
of utilizing the emergency department for sports-related TBI in the United States found 
that 15% of all TBI complaints in the emergency department are sports related among 0-
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19 year olds.  The most common sport causing TBI that required admission to the 
hospital was American football (Hanson et al. 2013). 
In addition, especially in the sports community, there is an increased incidence of 
repeated TBIs (Silver et al., 2011).  There was a specific study done by Guskiewicz et al. 
(2003) looking at the cumulative effects of repeat TBI on American college football 
players.  The prospective cohort study found that after following American college 
football players for three years, 6.5% of the players had repeat concussions within the 
same season, and those players who had had three previous TBIs were three times more 
likely to experience a fourth concussion than those who had no personal TBI history 
(Guskiewicz et al. 2003).  This could be due to a number of factors including the sport 
and style of play, the position of the player, increased playing time, and the fact that the 
brain could be at increased risk for injury after a first concussion (Meehan et al. 2009).  
Interestingly, there does not appear to be any evidence linking TBI with the action of 
heading a European football (American soccer ball) during play, according to a 
prospective cohort study done over the course of six years including 20 men’s and 
women’s FIFA tournaments (Fuller 2005).   
A complication of TBI that is experienced by many athletes is second-impact 
syndrome (SIS).  While technically not considered a repeat concussion, this can occur 
when an athlete experiences a second episode of trauma, such as a minor chest impact or 
direct head contact, while still symptomatic from a previous TBI.  This second-impact 
syndrome can lead to a significant and swift neurologic decline (Meehan et al. 2009).  
The mechanism causing the quick neurologic decline has been theorized; it is postulated 
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that the autoregulated blood flow over the cerebrum is upset, leading to “vascular 
engorgement and increase in intracranial pressure” followed by herniation of the 
cerebellum (Cantu 1995).  
 
Chronic Traumatic Encephalopathy 
Boxers in the 1920s suffering from chronic traumatic encephalopathy (CTE) 
before it was formally named were describes with terms such as punch-drunk, goofy, or 
slug-nutty (Gavett et al. 2011).  Then CTE was given the diagnosed name dementia 
pugilistica, meaning boxing dementia, because of its frequent presentation in retired 
boxers, however it was eventually realized that this pathology occurs in many other 
individuals, and was therefore named CTE.  DynaMed (March 2014) defines CTE as a 
“form of neurodegeneration related to repeated head injuries [that] can be associated with 
boxing, American football, hockey, professional wrestling, soccer, physical abuse” 
(DynaMed, March 2014).  Similarly to the risk of repeated TBI, the factors associated 
with likelihood of developing CTE in athletes include the specific “sport, position, 
duration of exposure, and age at the time of initial or subsequent head trauma, as well as 
with additional variables such as genetic predisposition” (Gavett et al. 2011).  While 
statistically, boxing has an 8-25% incidence of CTE, it appears that CTE only occurs in 
isolated incidences in American football (Silver et al., 2011).   
One specific difference between post-TBI symptoms and CTE is the fact that 
while post-TBI symptoms occur almost immediately following the injury, resolve within 
approximately thirty days, and “represent temporary states of neuronal and axonal 
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derangement,” CTE symptoms do not manifest until many years after full recovery from 
TBI (Gavett et al. 2011).  Additionally, CTE typically presents in mid-life following 
retirement from professional sports and has a gradual progression similar to other 
neurodegenerative diseases.  CTE, as described by the family members of individuals 
who suffered from it, effects behavior of the individuals in that they become more 
irritable, angry, and have shorter fuses.  Cognitive difficulties can also appear early in the 
disease process with deficits in episodic memory and executive functioning.  More 
progressive symptoms include abnormal movement, speech, and ocular movement, and 
the less common and most progressive symptom of dementia.  Sadly, a very unfortunate 
outcome of CTE has been shown to be suicide and/or suicide attempts (parasuicide), 
making the accurate assessment of the development of dementia difficult to determine 
and potentially under-represented, as those patients who commit suicide die at earlier 
ages than the onset of the final symptom (Omalu et al. 2010).  Another life-threatening 
symptom of CTE is the loss of inhibitory control in the brain, which can lead to death 
from accidents as well as put patients at an increased risk for problems with drug and 
alcohol abuse (Gavett et al. 2010).   
In general CTE is difficult to diagnose pre-mortem because there is a lack of 
concise diagnosis criteria (Gavett et al. 2010).  Additionally, the presentation of CTE can 
frequently appear similar to Alzheimer’s disease (AD), Parkinson’s disease (PD), and 
frontotemporal dementia (FTD), therefore eliminating those differential diagnoses is very 
challenging without the option for neuropathologic studies of the individual’s brain.  
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However, CTE is a distinct disorder from AD, PD, and FTD, as proven by post-mortem 
neuropathologic studies of the individual’s brains.   
There are gross pathologic as well as microscopic consistencies between CTE 
brains (Gavett et al. 2010).  Enlargement of the lateral and particularly the third ventricle 
is present in CTE (McKee et al. 2009).  There is atrophy of the frontal and temporal 
lobes, shrinkage of the mammillary bodies, and lightening in the color of the substantia 
nigra (Figure 3).  Atrophy is present in many other areas of the brain, causing a general 
reduction in total brain mass (McKee et al. 2009).   
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Figure 3. Coronal sections comparing normal brain and CTE brain.  A. Normal 
brain with normal ventricular and size relationship.  B.  CTE brain with widening of 
lateral ventricle (1), widening of the third ventricle (2), atrophy of the temporal structures 
(4), and shrinkage of the mammillary bodies (5) (figure amended from Stern et al. 2011). 
 
On a microscopic level, the three main proteins present in CTE are tau, beta-
amyloid (Aβ), and TDP-43 (McKee et al. 2009).  Tau makes up the neurofibrillary 
inclusions called neurofibrillary tangle (NFT), and while NFTs are also present in AD 
patients, they have a distinct distribution in CTE.  In CTE, NFTs are distributed to more 
confined areas of the frontal, temporal, and insular cortices and remain fairly superficial, 
whereas in AD the NFTs are distributed diffusely through the cortices and also invade 
large projection neurons deeper in the cortices (Figure 4).  Additionally, NFTs in CTE 
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are typically perivascular, indicating interference of the microvasculature and blood brain 
barrier (McKee et al 2009).   
 
 
 
Figure 4.  Comparing the presence of Tau protein in control versus CTE brains.  
Left. Hemi-section of a control brain immunostained for tau protein and counterstained 
with cresyl violet showing no brown tau deposition.  Right. Hemi-section of a CTE brain 
immunostained for tau protein and counterstained with cresyl violet showing extensive 
brown tau deposition in the frontal and temporal grey matter (BU CTE Center, 2015). 
 
 
Amyloid precursor protein (APP) is a protein that is known to be upregulated in 
patients who suffered a TBI and Aβ inclusions are present in 30% of patients who die 
immediately following a TBI (Gentleman et al. 1993).  Aβ protein deposits are present in 
40-45% of cases of CTE, in contrast to its 100% presence in ALS patients, and when Aβ 
are present in CTE, they are less dense and more diffuse (McKee et al. 2009).  It is 
unclear what the role of the excess APP and Aβ is in CTE, whether the protein’s presence 
in damaged axons leads to neurodegeneration or neuroprotection (Gentleman et al. 1993).   
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The final protein involved in CTE microscopic pathogenesis is TDP-43.  
Recently, it was found that there is a diffuse presence of pathogenic TDP-43 present in 
CTE brains (McKee et al. 2010).  Interestingly, there is also evidence showing that in 
individuals with CTE who also developed neurodegenerative diseases prior to death, 
there were TDP-43 inclusions extending into the spinal cord, specifically proteinopathy 
in the anterior horns of the spinal cord.  This disease process tends to clinically present 
very similar to ALS. 
It is not clear if the diagnosis of CTE must precede an ultimate development of 
ALS, because there is also evidence that shows an increased early onset ALS in Italian 
football players (American soccer) that is not considered to be a sport with large 
diagnosis of CTE (Chió et al. 2004).  This supports additional evidence to suggest that 
rigorous athletic activity could be responsible for MND, an additional term used for ALS.  
There are possible genetic factors associated with MND that are upregulated or altered 
due to physical activity and could therefore help connect these two events (Hardwood et 
al., 2009).  In addition, there seems to be an increase in neurotoxicity of TDP-43 
following TBIs; TDP-43 is the protein normally involved in neurofilament-binding and 
mRNA-stability.  Due to the similar immunoreactivity of TDP-43 in CTE and ALS as 
well as the increased association between TBIs and ALS, it appears that there may be 
similar mechanisms involved in the pathologic expression of TDP-43 (Costanza et al. 
2011).   
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Specific Aims/Objectives 
There is clear evidence of the relationship between extreme activity and an 
increased incidence of ALS.  There is also evidence showing that athletes who experience 
TBI or CTE tend to develop MND.  However, there has only been little done to 
determine how athletes, TBI, CTE, and ALS as well as other MNDs are all connected. 
This paper is aimed at discovering the relationship between athletics or strenuous 
exercise, TBI, CTE, and ALS. Specifically this thesis will examine: 
(1) The extent of athletes that are diagnosed with CTE during their extended years 
of activity and the development of ALS 
(2) The incidence of athletes developing ALS versus other MND and any 
potential differences in their mechanisms  
(3) The neurologic mechanism of athletes who develop ALS relative to those who 
develop ALS without having participated in multiple years of athletic activity. 
 
We hope this study will reveal a correlation between athletes diagnosed with CTE 
and the specific mechanism that is associated with CTE that leads to ALS.  Additionally, 
there could be a connection between the mechanism variation leading to ALS versus a 
different MND.  This could potentially help lead to further therapeutic implications for 
CTE and their success in prevention of the development of ALS as well as other MNDs. 
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PUBLISHED STUDIES 
 
TBI and PD 
 Prior to the article published by Annals of Neurology investigating the risk of PD 
following TBI, the epidemiologically evidence linking the two was inconsistent 
(Goldman et al. 2006).  There also appears to potential confounding factors, for example, 
head injury may be genetically related to high-risk behavior or careers such as farming.  
Goldman et al, undertook a study to attempt to eliminate these confounding factors and 
investigate the relationship of TBI and PD.  To control for the confounding factor of 
genetic high-risk behavior, the study evaluated twins, one with PD and one without PD.  
These twins are either genetically identical monozygotes or genetically very similar 
dizygotes, eliminating the genetic confounding factor.  Additionally, evaluating twins 
allowed for generally similar environmental exposures compared to typical cases and 
controls, eliminating environmental confounding factors.  This study successfully 
eliminated confounding factors including genetic predisposition, genetically associated 
high-risk behavior, and nonspecific “male lifestyle factors” because twins tend to behave 
similarly.    This study also evaluated twins who both have PD to determine if TBI causes 
acceleration in the development of PD.    
 Participants were not informed of the study hypothesis and the selected 
individuals were provided with a questionnaire where they indicated if they suffered a 
TBI resulting in loss of consciousness or memory loss, at what age the TBI occurred, and 
whether or not they were hospitalized for their TBI (Goldman et al. 2006).  Twins who 
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were both suffering from PD were evaluated separately from twins where only one twin 
had PD.  
 The study successfully showed that there is a significant relationship between TBI 
and associated PD with twins where only one of them had diagnosed PD(Goldman et al. 
2006).  Individuals evaluated were shown to be three times more likely to develop PD 
after experiencing TBI.  The risk of developing PD goes up significantly to four times if 
the individual has suffered two TBIs.  Interestingly, the associated risk for PD following 
TBI was shown in both monozygotic and dizygotic twins, however, it was found that 
there is an increase in the association of TBI leading to PD in monozygotic twins.  
The study also attempted to remove the possibility of the bias associated with a 
TBI being caused by the early motor changes in the not yet diagnosed but diseased 
Parkinson’s patients (Goldman et al. 2006).  In attempt to do this, the researchers 
excluded any individuals who had suffered a TBI within the ten years prior to the 
diagnosis of PD. As the average time of onset of PD following a TBI is thirty years, it 
was felt that removal of TBIs within ten years of the onset of PD was appropriate.  It 
appears that there is still a statistically significant direct causal relationship between TBI 
and subsequently developing PD.  Also excluded from the study were twin sets whose 
control non-PD twin died before the PD diagnosis in the other twin, attempting to 
eliminate a survival bias.  
When comparing twins who both were diagnosed with PD there was an 
association found that the twin who had suffered a TBI was likely to develop earlier onset 
of PD; potentially showing that TBI may lead to more rapid clinical expression of PD 
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(Goldman et al. 2006).  This finding, however, was not statistically significant and the 
number of twin sets both diagnosed with PD was small, therefore it requires further 
investigation. 
 An additional concern about the study is the increased frequency of TBI in the 
population when compared to the occurrence of TBI in previous studies (Goldman et al. 
2006).  This is potentially though to be partially due to the fact that all of the individuals 
in the current study were male and men are twice as likely to undergo a TBI in their 
lifetime.  Also the participants all participated in either World War II or the Korean 
conflict, some experiencing active combat that could lend itself to increased risk for TBI.  
Furthermore, more than 33% of participants grew up farming which is an occupation 
associated with increased risk for TBI.  
 According to the Goldman et al. (2006) study, the proposed biological causes of 
TBI leading to PD have several potential elements.  There is an inflammatory response 
that begins to occur in the brain within minutes of a TBI and this response can last for 
months.  Initially, the blood brain barrier breaks down followed by leukocyte infiltration 
and microglial (a central nervous system immune cell) activation.  In PD patients, there is 
an ongoing inflammatory response occurring in the substantia nigra pars compacta and 
inflammation in this area of the brain following a TBI can last for decades.  Additionally, 
mitochondria function becomes decreased leading to an increased production of free 
radicals, and mitochondrial dysfunction is present in many PD cases, but its role is in the 
disease progression remains unclear.  Finally, TBI increases the production of tau protein 
and synuclein; these two proteins together contribute to proteinopathy and inclusions of 
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each other. Alpha-synuclein is a known component of Lewy bodies, which are 
accumulated in PD brains and essential for post-mortem diagnosis of PD. 
 Goldman et al. (2006) proposed a potential treatment following TBI that could 
help prevent PD.  The average period of dormancy of 30 years before onset of PD is 
clinically significant.  It appears that this prolonged period between TBI and PD is 
essential for the full degeneration of the brain, however, it also allows for the opportunity 
for extensive intervention in the years following the injury.  As the inflammatory 
response of the brain appears to contribute to PD, it seems that the use of 
antiinflammatory medications could help reduce risk for developing PD.  This specific 
treatment needs to be investigated further, but it does appear to be a plausible solution, as 
there have been two studies confirming the therapeutic use of antiinflammatories in 
preventing PD following TBI. 
 
Rigorous Physical Activity and ALS  
 According to a study done by Chiò et al. (2004), prior to their study, the 
hypothesis that participation in sports had been proposed since the 1970s without 
consistent results.  The Chiò et al. (2004) study was inspired by an investigation into the 
cause of death of in a cohort of 24,000 Italian football (IF) players (American soccer 
players), which turned up with a statistically unusually high number of deaths attributed 
to ALS.  Based on standard population statistics, the expected number of incidences of 
ALS-related deaths in the 375 athletes who were deceased was 0.69, however there were 
8 deaths attributed to ALS (Chiò et al. 2004).  The goal of their study was to 
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retrospectively investigate the potential cause of developing ALS amongst this 
disproportionately large number of ALS-caused deaths in IF players.  
 For their study they used all male professional IF players who played in Italian 
First or Second Divisions between September 1, 1970 and June 30, 2002 (Chiò et al. 
2004).  The individuals had to have played at least one official game.  The age at which 
the participants played Italian football, their position on the field, and the number of years 
they participated in the professional sport were all included and evaluated for statistical 
significance in developing ALS. 
 To assure the individuals were indeed suffering from ALS, conformation was 
obtained from multiple sources including death certificates, the archives of the Italian 
ALS Association, and self-report as well as family report (Chiò et al. 2004).  Each ALS 
case was further investigated by obtaining detailed information from the individual, 
family members, healthcare providers about the patient’s past personal and medical 
history, work and trauma following retirement from Italian football, exposures to 
potentially toxic environmental factors, as well as thorough family history focused on 
neuromuscular disease.  
 It was found that out of the total 7325 professional IF players, there were fifteen 
Italian-born IF players who played IF between 1970 and 2001 who were diagnosed with 
ALS (Chiò et al. 2004).  Interestingly, none of the five individuals had suffered an injury 
significant enough to require hospitalization nor had they been exposed to metals or 
solvents.  To determine the expected number of incidence of ALS in the normal Italian 
population they utilized the northern Italy and southern Italy Registers for ALS.  
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Applying this expected incidence of ALS within the subgroup of 7325 professional 
athletes, it was determined the expected incidence of ALS including subgroups of 
number of years played, position played, and age of the player.  It was found that in in all 
three cases, the incidence of athletes who developed ALS was statistically significantly 
higher in the cohort IF players when compared to the general Italian population (Tables 
4-6).  
 
Table 4. ALS incidence by age classes. This is a comparison of the expected incidence 
of ALS within the 7325 cohort of IF players and the actual incidence of ALS found 
separated into age class onset (table amended from Chiò et al. 2004). 
 
Age Classes Expected Cases Observed Cases 
15-49 0.53 4 
50-69 0.24 1 
 
 
Table 5. ALS incidence by playing position. This is a comparison of the expected 
incidence of ALS within the 7325 cohort of IF players and the actual incidence of ALS 
found separated by position played (table amended from Chiò et al. 2004). 
 
Playing 
Position 
Expected Cases Observed Cases 
Forward 0.09 - 
Midfield 0.33 4 
Back 0.24 1 
Goalkeeper 0.11 - 
 
 
Table 6. ALS incidence by number of years as a professional IF player. This is a 
comparison of the expected incidence of ALS within the 7325 cohort of IF players and 
the actual incidence of ALS found separated by number of years as a professional player 
(table amended from Chiò et al. 2004). 
 
Number of 
years 
Expected Cases Observed Cases 
≤ 5 years 0.57 2 
> 5 years 0.20 3 
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 This was the first large prospective cohort study to show a high significant 
causation between playing professional Italian football and ALS (Chiò et al. 2004).  
Playing professional IF was found to be the strongest potential risk factor for developing 
ALS as of yet.  It was also clearly demonstrated that the more number of years an 
individual played professionally lead to an increased risk of ALS as well as the average 
age onset of ALS amongst Italian football players being somewhere near 20 years earlier 
than the average age of onset in the general population.  There was also an abnormally 
high percentage of clinically bulbar ALS by comparison to the ALS Registers.   
 The causative factoring leading to ALS is still unknown leading to the proposal of 
new hypotheses: 
i. ALS could be cause solely by participating in strenuous physical activity 
and is not directly linked to IF. 
ii. ALS is caused by traumas that could be IF specific such as heading the 
ball, leg traumas, or training trauma. 
iii. ALS is related to the use of illegal substances used to attempt to improve 
performance. 
iv. ALS is related to toxic herbicides or fertilizers used on IF fields.  
 
It was concluded that ALS being caused by strenuous physical activity is unlikely 
as previous studies have been inconclusive (Chiò et al. 2004).  IF specific trauma is still 
possible as trauma has been indicated to be a risk factor for ALS.  The bulbar clinical 
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presentation of ALS could be linked with heading a ball, an IF specific head trauma.  It 
remains possible that the early age onset of ALS within the cohort of IF players could be 
caused by the toxic substances in fertilizers and herbicides, however, toxins leading to 
ALS are still generally unidentified.  Further studies evaluating environmental exposures 
as well as the pathology of ALS are required. 
 
Rigorous Physical Activity and MND/ALS: A Review  
 
 An article published in the Journal of Amyotrophic Lateral Sclerosis in 2009 
reviewed previously published studies on strenuous exercise and ALS, called NMD in the 
study.  According to the review, the etiology of most cases of ALS is not clear but seems 
to be a combination of fixed genetic predisposition and environmental factors (Hardwood 
et al. 2009).  There are nine genetic mutations that currently give rise to ALS via familial 
inheritance with a most recent discovery of the pathologic power of TDP-43.  There is 
thought to be a genetic component to sporadic onset ALS, although the evidence is 
lacking.  The genes thought to cause predisposition for ALS have been suggested to be 
angiogenin, survival motor neuron, and haemochromatosis but again, findings are 
inconsistent. 
 Environmental factors that have been demonstrated to contribute to ALS are 
currently male gender, family history, increasing age, and smoking; however, smoking as 
a risk factor is still debated (Hardwood et al. 2009).  Most studies up to this point 
investigating activity as a factor in ALS have had issues with confounding factors, 
selection bias, small sample sizes, and additional environmental exposures.  This article 
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by Hardwood et al. (2009) reviews the evidence surrounding general and sport-specific 
physical activity as a risk factor for ALS.  Eleven previously published studies since 1995 
were found using the terms ‘ALS’ or ‘MND’ and “physical activity’ or ‘sport’ or 
‘exercise’ or ‘football’.   The overall findings from each study were summarized (Table 
7). 
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Table 7.  Summary of published studies investigating physical activity and ALS.  
These studies were found to be the most relevant and provided conclusions conducive to 
a literature review of the evidence for rigorous activity as a risk factor for ALS (Table 
amended from Hardwood et al. 2009). 
 
 
  
The first five articles listed in Table 7 had the goal of investigating general 
physical activity and ALS (Hardwood et al. 2009).  The following six articles were aimed 
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to evaluate soccer as a risk factor for ALS.  Based upon these eleven studies, the evidence 
that physical and athletic activity increases an individual’s risk for ALS is inconsistent.  
No significant conclusions can be made from these studies, as there were noteworthy 
issues within the structure of the majority of the studies.  Some key problems 
encountered include selection bias, poor study definitions, attempted investigation of 
multiple hypotheses in individual studies, and small participant numbers.  An additional 
factor affecting these outcomes is the relatively small amount of cases of ALS in general, 
as the disease is quite rare.  It is clear, though, that the outcome in several of these studies 
did show a positive relationship between rigorous physical activity and this needs to be 
investigated further. 
 The Harwood et al. (2009) review also presented the potential biological and 
genetic relationships of athletic activity and ALS (Hardwood et al. 2009).  Non-ALS 
research has found that strenuous activities modify several mechanisms, including the 
oxidative stress process.  There is already substantial evidence in post-mortem ALS 
patients that oxidative damage of the nervous system is a contributor to the disease.  It is 
reasonable then that intense use of the muscles of the body leads increased metabolism in 
the body, and therefore excessive free radial production and an increase in reactive 
oxygen species.  The normalizing process of the body to increase antioxidant enzyme 
activity during moderate exercise is thought to not occur or occur less successfully in 
extreme exercise including professional sports, therefore causing the buildup of reactive 
oxygen species and damaging effects to the cells of the body, including cell death.  
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 Another proposed biological mechanism is glutamate excitotoxicity (Hardwood et 
al. 2009).  While glutamate is a common and necessary neurotransmitter, in excess, it can 
be detrimental.  During intense exercise, motor neurons are required to fire extremely 
quickly and frequently, leading to an increase in the release of glutamate.  This large 
amount of neurotransmitter leads to large calcium influx into the neuronal cells, toxicity, 
and finally cell death.  This proposition seems to be supported by the small benefit 
provided by the drug Riluzole, which inhibits glutamate release from presynaptic 
terminals of neurons 
 There are several proposed genetic predispositions that are theorized to link 
physical activity and ALS (Hardwood et al. 2009).  MND patients have been found to 
have mutations in their hypoxia-induced genes.  As motor neurons have such a high 
oxygen demand, it is plausible that these neurons are at a higher risk of death than other 
cells if their response to hypoxia is faulty.  Variations in the vascular endothelial growth 
factor (VEGF) gene have been previously tied with ALS  Decreases in the amount of 
serum VEGF and altered VEGF protein have been found in ALS patients.  Intriguingly, 
in control individuals, VEGF is found to increase in serum and VEGF receptor 
transcription is upregulated.  Angiogenin, an additional hypoxia-response gene that works 
in tandem with VEGF, is normally upregulated during heavy exercise, but is found to 
mutant in ALS patients  Individuals with these gene abnormalities could certainly lack 
the ability to amount the appropriate response to extreme exercise and be as risk for 
motor neuron death. 
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 Neurotrophic factors, including ciliary neurotrophic factor (CNTF) as well as 
others, have been found to be protective to motor neurons in cultures and animals 
(Hardwood et al. 2009).  Mutations in CNTF are associated with early onset ALS in 
individuals with other genetic predispositions.  CNTF is also found to be in at unusually 
high levels in the serum of ALS patients, and it is also upregulated in the motor neurons 
of the spinal cord.  Neurotrophic factors are increased during exercise; it was found that 
in mice placed on a 21-day exercise regimen, CNTF was upregulated two fold. 
These genetic predispositions appear to be a potential link between strenuous 
exercise and ALS (Hardwood et al. 2009).  It was recognized that further studies should 
integrate epidemiology and basic science to lead to consistent and clear evidence.  While 
the previous epidemiologic studies have had flaws, including these biological and genetic 
factors will strengthen the outcome.  Successfully identifying rigorous activity as a risk 
factor for ALS will give specific direction to potential therapeutic endeavors.   
  
TBI and ALS  
 A study published in the American Journal of Epidemiology in 2007 was a direct 
response to the published study done in 2004 evaluating IF as a risk factor for ALS.   
While the study on IF players concluded that repeated traumas might be a risk factor for 
ALS, this study aimed to further investigate the relationship between head trauma as well 
as trauma to other parts of the body, and the later development of ALS (Chen et al. 2007).   
 Participants in this study were gathered from the Neuromuscular Research Unit at 
Tufts-New England Medical Center and the Neurophysiology Center at Brigham and 
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Women’s Hospital in Boston, Massachusetts (Chen et al. 2007).  A total of 109 patients 
were selected for the study based on the criteria that they had to have been diagnosed 
with ALS by the World Federation of Neurology standard, diagnosed within the previous 
two years, live in New England more than 50% of the year, and exhibit mental 
competence.  Population controls were selected based on the same criteria except they 
could not have been diagnosed with ALS, Parkinsonism, dementia, neuropathy, or any 
other neurodegenerative disease.  A total of 255 controls were matched based on age, 
gender, and area code in a 3:1 or 2:1 ratio to ALS participants. 
 For gathering history about the cases as well as controls, the individuals were 
asked if they had ever experienced trauma that required medical attention (Chen et al. 
2007).  They were also asked their age when they sustained the trauma and on what body 
part the trauma occurred.  Up to three injuries were included in the study.  Additional 
social history, including smoking cigarettes as well as highest level of education, were 
also questioned as these appear to already be considered risk factors for ALS. 
 The study also included a meta-analysis of seven of the right previous 
publications about TBI and ALS; one study was left out due to inconsistencies and risk 
estimation was unable to be calculated (Chen et al. 2007).  Cases and controls were 
separated into groups according to exposures of “ever vs. never,” with regard to general 
injury as well as location of injury and injury that had more than one body location.  This 
was also adjusted for “never vs. ever” for smoking and “high school or less vs. more than 
high school” for level of education.  Overall, it was found that having sustained an injury 
requiring hospitalization or medical attention did not increase an individual’s chances of 
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developing ALS.  However, when comparing all of the body parts, it did appear that there 
was a strongest causal relationship between head injury as a risk factor for ALS except it 
was not statistically significant.   
 Individuals who endured repeated TBIs or suffered a head injury within the ten to 
three years prior to diagnosis were found to be three times more at risk for developing 
ALS (Table 8).  Further investigation found that individuals who had experienced 
multiple TBIs with the most recent one occurring in the last ten years had an eleven-time 
increase in their risk for ALS (Chen et al. 2007).  Cases with a history of multiple TBIs 
were additionally found to be more likely to develop bulbar clinical presentation; they 
were 33.3% of cases when compared to the rate of bulbar presentation of 22.4% within 
the cases.  Lastly, the average age of onset of ALS was 54 years for individuals with 
multiple TBIs in their past compared to the average of all of the cases having the average 
age of onset of 59.5 years. 
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Table 8. ALS associated with physical injury.  This compares case individuals versus 
controls in the type of injury sustained as well as the number of years since their injury 
(table amended from Chen et al. 2007).   
 
 Cases (n = 109) Controls (n = 255) 
No. of head injuries   
0 (Never injured) 78 83.5 
1 11.9 12.5 
>1 10.1 3.9 
   
Years since last injury   
0 (Never injured) 78 83.5 
>30 4.6 5.9 
11-30 10.1 8.2 
≤10 7.3 2.4 
   
No. of head injuries and years since last 
injury 
  
0 (Never injured) 78 83.5 
1 injury at any time 11.9 12.5 
>1 injury with the last one >10 years prior 6.4 3.5 
>1 injury with the last one ≤10 years prior 3.7 0.4 
   
Age (years) at last injury   
<30 78 83.5 
30-40 11.9 12.2 
>40 2.8 2 
 7.3 2.4 
   
Involvement of other body sites in the same 
incident 
  
Never injured 78 83.5 
Head only 14.7 12.2 
Head with other body sites 7.3 4.3 
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 This study by Chen et al. (2007) as well as the meta-analysis of previous studies 
evaluating the relationship of TBI and ALS, are consistent with the recent findings of the 
study of IF players.  While this study was unable to completely exclude the possibility of 
the preclinical symptoms of ALS causing injury, it seems that it can potentially rule it out 
as a cause, as merely sustaining an injury did not show to be a risk factor for ALS.  This 
issue was also attempted to be addressed as cases who sustained a significant injury 
within the previous three years were not included in the study.  Additionally, this study 
gave more specific parameters to the nature of the trauma sustained by the individuals 
participating; lack of specificity in regards to the type of trauma was an issue with 
previous studies and in the past gave inconclusive results.  Unfortunately, the biology of 
TBI and ALS was not investigated and is still unknown.  It is clear, however, that the 
mechanisms of inflammation, blood brain barrier disruption, and mitochondrial 
dysfunction involved in progression of PD following TBI should be considered as 
potential proponents of ALS as well. 
 
CTE and ALS 
 McKee et al. (2010) had an article published by the Journal of Neuropathology 
and Experimental Neurology in 2010 directly investigating the differences in the post-
mortem brains of individuals with diagnosed CTE alone compared to the post-mortem 
brains of those with CTE with ALS.  This study was directly inspired by the published 
articles of Chiò et al. (2004) and Chen et al. (2007) as well as several others.  TDP-43 
inclusions were originally thought to be unique to ALS; however, it is now known that 
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TDP-43 protein pathologies are present in a multitude of neurodegenerative diseases, 
including CTE (McKee et al. 2010).  This study directly compared the presentation of 
TDP-43 in twelve control brains and spinal cords, twelve sporadic onset ALS brains and 
spinal cords, and the brains and spinal cords of twelve former athletes with diagnosed 
CTE, three of which had clinical symptoms of ALS.   
These subjects were all matched for age and gender (McKee et al. 2010).  Prudent 
information of the deceased individuals was obtained through history of trauma, behavior 
history, motor symptoms, and status at the time of death both through the medical record 
and interviews when possible and/or necessary.  Two of the three individuals with MND 
presentation played professional football and one was a professional boxer.  The three 
individuals with CTE and ALS all had clinical presentations of severe muscle atrophy, 
weakness, and fasiculations, beginning in the upper extremities, neck, and shoulders with 
bulbar signs following shortly after.  Sections of these brains were processed and stained 
for tau, TDP-43, ubiquitin, alpha-synuclein, and Aβ, as well as several others.  The 
processing procedure was established by Boston University Alzheimer’s Disease Center, 
Mount Sinai Alzheimer’s Disease Center, and Massachusetts Alzheimer’s Disease 
Research Center Brain Bank. 
In the sporadic ALS cases, TDP-43 was ever present as expected in variable 
manifestations within the tissue and rarely was there tau protein present (McKee et al. 
2010).  The cases of CTE without ALS manifestations appeared consistent with CTE 
with tau-positive NFTs in the frontal and temporal lobes as well as the basal ganglia and 
brain stem and TDP-43 as inclusions in the shapes of rings and filaments were 
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widespread through the frontal and temporal cortex, subcortical white matter, and 
brainstem.  The three brains with both CTE and ALS appeared very similar to the CTE 
only brains with the exception of atrophy of the ventral roots of the spinal cord.  The CTE 
and ALS brains also had extensive tau NFTs and TDP-43 ring and filament shaped 
inclusions, but interestingly these cases had a substantial increase in the amount of TDP-
43 rings and filaments within the brain tissue and spinal cord when compared to CTE 
alone. 
Two of the three CTE plus ALS cases had more severe MND and were found to 
have remarkable amounts of astrocytosis and loss of myelin and axons in the lateral 
corticospinal tracts (McKee et al. 2010).  The ventral roots of the spinal cord were 
atrophies and there was a marked reduction in the number of anterior horn cells.  
Additionally, there were activated inflammatory cells, microglia and macrophages, 
diffusely distributed through the brains and spinal cords of these two cases.  Tau NFTs 
were also found in the posterior, lateral, and ventral horns of the spinal cord.  
As it is already clearly known that TDP-43 inclusions are presents in ALS 
patients, McKee at al. (2010) also have found these inclusions in 80% of CTE with the 
expected presence of tau NFTs (McKee et al. 2010).  The individuals with CTE that 
developed ALS later in their disease process had both the TDP-43 and tau NFT proteins 
but additionally had these pathologies present in their spinal cords.  The simultaneous 
presence of both tau and TDP-43 pathogenic forms implies that a similar mechanism is 
responsible for the accumulation of these proteins, and that CTE with MND is not a 
happenstance.   
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TBI causes the brain and spinal cord to experience shear stretching of the axons 
(McKee et al. 2010).  During attempted repair of these damaged axons, there can be 
pathologic accumulation of neurofilament proteins.  As TDP-43 is prone to aggregation, 
during its upregulation and involvement in the repair mechanism for axon damage, there 
is an opportunity presented for problematic aggregate formation.  It is possible then that 
sports such as football and boxing lead the pathologic accumulation of TDP-43 in the 
brain and in some cases accumulation of TDP-43 in the spinal cord.  It remains unclear 
what causes these anatomical changes to remain in the brain versus extend into the spinal 
cord. 	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DISCUSSION 
 
 	   As demonstrated by this review of the previously published articles, it is clear that 
trauma to the head can have long-term neurologic side effects including development of a 
multitude of diseases such as PD, AD, and ALS.  Goldman et al. (2006) successfully 
eliminated potential confounding factors such as occupation, genetic predisposition to 
particular behavior, and environmental exposures in their investigation about the 
relationship between TBI and PD.  It was found that even a single significant TBI could 
cause the terminal illness of PD.  The proposed mechanism behind this development was 
the inflammatory response within the neural tissue that is present following a TBI and is 
also present in individuals diagnosed with PD (Goldman et al. 2006).  However, this 
relationship needs to be further explored to determine the significance of CTE versus 
single TBI and PD, as well as the causes that allow TBI to lead to PD versus ALS, if 
there is a similar response occurring in the brain following a TBI in either case.  This 
could certainly be related to genetic predisposition in individuals as well as a unique 
inflammatory response from person to person.  Also, a better confirmation that 
inflammation is a potential causation to PD following TBI should be investigated in the 
future, as it is considered a risk factor for PD but has not been confirmed.  Pathologic and 
anatomic studies would be best suited to validate inflammation as the main side effect of 
TBI that leads to PD. 
 The study by Chió et al. (2004) appeared to be conclusive in examining the 
relationship between professional athletes and ALS with strong statistical significance on 
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the increased prevalence of ALS within the professional athletic community.  While there 
were several proposed explanations to this finding, it appears that the most valid 
possibility is repeated microtraumas to the brain during the contact sport (Chió et al. 
2004).  The review of studies inquiring the relationship between rigorous activity as well 
as soccer leading to ALS demonstrated that there were flaws within the soccer and ALS 
articles, such as small sample sizes and selection bias.  The issues found in the Chió et al. 
(2004) study included testing multiple hypotheses as well as the lack of evaluation of 
environmental confounding factors such as smoking.  Additionally, the study used 
comparative measures with the general population incidence of ALS, which could be 
unsuitable, given that IF players could represent a genetically unique group of 
individuals.  The studies interested in the relationships between physical activity and 
ALS that were reviewed by Hardwood et al. (2009) had extremely inconsistent outcomes 
and more generally lacked proper definitions for cases and controls.  Hardwood et al. 
(2009) did also propose some potential biologic explanations behind why exercise could 
lead to ALS.  These ideas should be evaluated as it appears they are an area lacking 
information, but when studied thoroughly, could provide significant insight into this 
relationship. 
 The Chen et al. (2007) response research to the review of ALS and physical 
activity as well as soccer was successful at essentially eliminating a substantial 
relationship between general trauma in the general population and the development of 
ALS.  While the study removed the physical activity element from the possibilities of 
causes, it opened up the cases to include persons in the general population, eliminating 
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the potential problem of genetic predisposition of the soccer players.  This research was 
particularly important as it identified that the most significant risk factor found for 
developing ALS was multiple TBIs as well as more recent TBIs (Chen et al., 2007).  This 
perpetuated further investigation into the biological mechanisms and changes to the brain 
following multiple TBIs. 
 As CTE is a rather newly defined disease that typically involved athletes, there 
have been new and profound investigative studies about the pathology of the disease and 
damage that multiple TBIs has on the brain to explain the long-term clinical presentation.  
CTE is most common among athletes, and there seems to be a relationship between 
athletes and ALS, as well as multiple TBIs and ALS.  Since the association of repeated 
TBIs and ALS exists, it seemed reasonable to investigate a possible relationship between 
CTE and ALS, as multiple TBIs leads to CTE. 
 McKee et al. (2009) was able to successfully identify the unique neuropathology 
of CTE at an anatomic level.  Based on the relationships of multiple TBI, athletes, and 
ALS that had been found, McKee et al. (2009) successfully distinguished the pathologic 
variances between sporadic ALS, CTE alone, and CTE with ALS.  This study was the 
first to identify the biologic differences of CTE versus ALS.  There were distinct 
similarities between the CTE and CTE with ALS brain tissues of these former football 
players and boxer as they both had TDP-43 and tau depositions.  The most exciting 
finding was that CTE and ALS patients had these depositions within their spinal cords as 
well.  This could imply that CTE is an additional risk factor for developing ALS, as the 
presence of the tau depositions is unique to CTE when compared to ALS alone.   
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 With this anatomical information, it seems prudent that there should be further 
research to determine what would cause one individual to have pathogenic destruction 
limited to the brain tissue whereas another individual who suffered from CTE has 
damage that extends beyond the brain tissue to the spinal cord, causing MND.  As not all 
individuals who undergo multiple TBIs develop CTE, it could be assumed that there is a 
genetic predisposition that with the appropriate environmental experiences triggers the 
later development of the disease.  In the same light, there could certainly be a genetic 
factor that causes certain individuals to develop CTE initially, followed by ALS.  
Research should be focused on discerning what those genetic variables could potentially 
be, as experiencing CTE and ALS simultaneously is an even more devastating terminal 
situation. 
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CONCLUSION 
 
 There is certainly evidence to support the notion that participation in professional 
sports with associated head traumas can cause neurologic issues including the 
development of ALS, however general exercise without trauma as a risk factor for ALS 
still remains inconclusive.  It is postulated that it could be a risk factor for individuals 
predisposed to problems such as poor response to increased metabolism, lack of 
neuroprotective elements, and inability to adequately remove oxidative elements from the 
body, but this has not been examined.  There is also inconsistent evidence about the 
relationship between soccer and ALS as many of the studies on this subject had a 
multitude of confounding issues.   
The concept of even a single TBI potentially leading to PD has fairly significant 
data to support it (Goldman et al. 2006).  The proposed explanation for this is the 
inflammation of the brain as a response to TBI, though this has not yet been researched.  
There is also a clear causative relationship between individuals suffering multiple TBIs 
and later developing ALS, and as this association seems quite strong, the risk factor of 
soccer for ALS could potentially be explained by repeated TBIs suffered while playing 
the sport (Chen et al., 2007).  The same study also effectively ruled out any noteworthy 
relationship between suffering trauma to other parts of the body besides the head, as there 
was rarely a statistical difference in the prevalence of ALS between cases and controls.   
There is an anatomical difference between ALS, CTE, and CTE with ALS that is 
clearly demonstrated through post-mortem staining of brain and spinal tissue.  This data 
supports the hypothesis that CTE can be a risk factor for ALS, as long as ALS has a 
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separate neuropathological presentation in tissue than does ALS following CTE.  The 
reasons as to why one individual suffers CTE versus both CTE and ALS were not 
speculated, and this needs to be further investigated to determine why CTE is a risk factor 
for developing ALS. 
As there is generally a large time window between initial TBIs and the much later 
development of PD, CTE, and/or ALS, it seems that discovering the biological and 
genetic factors involved in these diseases is essential.  It is not fully known what changes 
in the brain and spinal cord are occurring during this extensive, relatively clinically 
dormant period of time.  As there is such a significant delay in the onset of these terminal 
diseases, this would potentially allow for years of intervention and treatment, and 
possible prevention and/or delay of disease development overall.  There is still extensive 
knowledge to be gained about these injuries, these diseases, and how they related to each 
other. 
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